- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06867133
The Evaluation of the Curative Effect of Electrophysiological Rehabilitation Services on Endometrial Repair After Induced Abortion (rehabilitation)
Exploring the efficacy evaluation of electrophysiological rehabilitation services in endometrial repair after induced abortion, providing scientific basis for medical institutions and government post abortion care decision-making.
This study is a multicenter randomized controlled intervention study. The main endpoint of the study was the measurement of endometrial thickness by transvaginal ultrasound on days 21-23 after abortion.
Secondary study endpoint:
- Postoperative uterine contraction pain;
- Patient satisfaction;
- Menstrual recurrence time;
- Changes in menstrual flow for two consecutive periods after surgery;
- The duration of two consecutive menstrual periods after surgery.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Xinyan Liu, Ph.D
- Phone Number: +86 186 0000 8013
- Email: 4826645@qq.com
Study Locations
-
-
-
Beijing, China
- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
-
Contact:
- Xinyan Liu, Ph.D
- Phone Number: +86 186 0000 8013
- Email: 4826645@qq.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Female aged 18-40 years old;
- Previous menstrual patterns;
- Pregnancy duration 6-10 weeks;
- Ultrasound indicates intrauterine pregnancy;
- Voluntarily accepting surgical induced abortion with no contraindications for induced abortion;
- Voluntarily participate in the trial and sign the informed consent form.
- Patients or their families are able to understand the research protocol and are willing to participate in this study, providing written informed consent.
Exclusion Criteria:
- Medical abortion patients;
- Patients with pelvic and abdominal benign and malignant tumors and other systemic diseases; C) Skin problems such as ulceration, infection, and blisters at the treatment site;
d) Patients with missed miscarriage diagnosed clinically; e) Patients with combined uterine fibroids, adenomyosis, and uterine malformations; f) Those who have inserted intrauterine devices (including copper containing intrauterine devices and levonorgestrel containing intrauterine devices); g) Individuals who have had three or more previous induced abortions; h) Clinical diagnosis of thin endometrium; i) Individuals with a history of cesarean section surgery; j) Individuals with severe mental illnesses; k) Researchers determine other situations that are not suitable for participating in this study; l) Patients or their families are unable to understand the conditions and objectives of this study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Electrophysiological Rehabilitation Group
On the basis of treatment in the control group, postoperative electrophysiological rehabilitation services were started for 30 minutes each time, once a day, for 6 consecutive days as one course of treatment, for a total of one course of treatment. The patch is located at the projection site of the lower abdomen uterus as shown in the figure, simulating bioelectric stimulation parameters: biphasic pulse current, frequency 2Hz, pulse width 3ms. Simultaneously conducting family health education, including but not limited to:
|
On the basis of treatment in the control group, postoperative electrophysiological rehabilitation services were started for 30 minutes each time, once a day, for 6 consecutive days as one course of treatment, for a total of one course of treatment. The patch is located at the projection site of the lower abdomen uterus as shown in the figure, simulating bioelectric stimulation parameters: biphasic pulse current, frequency 2Hz, pulse width 3ms. Simultaneously conducting family health education, including but not limited to:
|
|
No Intervention: control group
Accept routine health education and follow-up after induced abortion surgery, excluding specialized home health education services and biomimetic electrical stimulation therapy.
Pay attention to postoperative recovery, usually through telephone or outpatient follow-up, and receive routine anti infective treatment after surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Transvaginal ultrasound examination is used to measure the thickness of the endometrium.
Time Frame: On the 21st to 23rd day after abortion.
|
On the 21st to 23rd day after abortion, vaginal ultrasound was used to measure endometrial thickness.
|
On the 21st to 23rd day after abortion.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative uterine contraction pain
Time Frame: One week after surgery
|
The degree of postoperative pain was evaluated using the Visual Analogue Scale (VAS) scoring method.
A horizontal line of 10 cm in length was drawn, with the two ends representing 0 and 10 respectively.
0 indicated no pain, and 10 represented the most unbearable pain that could be imagined.
Patients were asked to select the corresponding number based on their postoperative pain sensation to describe the intensity of their subjective pain.
The time for postoperative pain assessment was as follows: for the experimental group, the VAS pain score was evaluated before treatment on the second day after surgery and after one session of bioelectrical stimulation treatment; for the control group, the VAS pain score was evaluated only once on the second day after surgery.
|
One week after surgery
|
|
Patient satisfaction
Time Frame: 3 months after surgery
|
Survey the satisfaction levels of patients in the control group and intervention group, specifically covering sub item satisfaction evaluations of biomimetic electrical stimulation treatment, doctor attitude, abortion process, and extended home rehabilitation services.
Each item is divided into five levels: very satisfied, satisfied, average, dissatisfied, and very dissatisfied.
In addition, the overall satisfaction of the above four items will be comprehensively evaluated.
|
3 months after surgery
|
|
Menstrual recurrence time
Time Frame: 3 months after surgery
|
Observe the time of menstrual recurrence in two groups after surgery, that is, the interval between the completion of induced abortion and the recurrence of menstruation in the subjects.
|
3 months after surgery
|
|
Changes in menstrual flow for two consecutive periods after surgery
Time Frame: 3 months after surgery
|
Understand the postoperative menstrual flow of the research subjects for two consecutive periods.
The specific reference criteria are: compared with the preoperative menstrual flow, it is divided into five levels: much more, slightly more, similar, slightly less, and much less.
|
3 months after surgery
|
|
Duration of two consecutive menstrual periods after surgery
Time Frame: 3 months after surgery
|
By conducting a 3-month online follow-up on the control group and intervention group, we aim to understand the duration of continuous menstruation in the study subjects after surgery.
|
3 months after surgery
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ChiCTR2400091098
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Supporting Information Type
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometrium
-
Fertigo Medical LtdKaplan Medical CenterCompleted
-
Aristotle University Of ThessalonikiCompleted
-
Sun Yat-sen UniversityUnknown
-
Heilongjiang University of Chinese MedicineCompletedEndometrium; SenilityChina
-
Nanjing UniversityUnknown
-
Ibn Sina HospitalGanna HospitalCompleted
-
Kaohsiung Veterans General Hospital.UnknownEndometrium | LaserTaiwan
-
Peking Union Medical College HospitalMerck Serono International SACompletedPostmenopausal EndometriumChina
-
The Fourth Affiliated Hospital of Zhejiang University...RecruitingThin Endometrium | Diminished Ovarian Reserve (DOR)China
-
Eli Lilly and CompanyGynecologic Oncology GroupCompletedNeoplasms | Urogenital Neoplasms | Neoplasms by Site | Uterine Neoplasms | Genital Neoplasms, Female | Endometrial Neoplasms | Endometrial Cancer | Endometrium Cancer | Cancer of Endometrium | Cancer of the Endometrium | Neoplasms, EndometrialUnited States
Clinical Trials on Electrophysiological rehabilitation
-
Hospices Civils de LyonCompleted
-
Centre Hospitalier St AnneRecruitingPathology Requiring Deep Brain Stimulation TherapyFrance
-
University of CalgaryRecruitingPhysiology | Cerebrovascular CirculationCanada
-
Luca ValciCompletedCerebral AneurysmSwitzerland
-
Hadassah Medical OrganizationUnknownParkinson's DiseaseIsrael
-
Assiut UniversityNot yet recruitingWolff-Parkinson-White Syndrome
-
Medtronic Cardiac Rhythm and Heart FailureCompletedHeart FailureIsrael, Belgium, Poland, United Kingdom
-
Maxima Medical CenterNot yet recruitingPregnancy | Monitoring
-
Medtronic Cardiac Rhythm and Heart FailureCompletedHeart FailureSweden, Slovakia, Poland, Spain, United Kingdom
-
Assistance Publique Hopitaux De MarseilleUnknown